Memphasys (ASX:MEM) ROCE % : -50.28% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Memphasys ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Memphasys's annualized ROCE % for the quarter that ended in Jun. 2024 was -50.28%.

Memphasys ROCE % Historical Data

The historical data trend for Memphasys's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Memphasys ROCE % Chart

Memphasys Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

-17.34

-11.96

-13.98

-33.04

-49.46

Memphasys Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-20.23	-19.19	-40.72	-50.22	-50.28

Memphasys ROCE % Calculation

Memphasys's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-4.025	/	( ( (14.668 - 5.567)	+	(12.43 - 5.254) )	/ 2 )
	=	-4.025	/	( (9.101	+	7.176)	/ 2 )
	=	-4.025	/	8.1385
	=	-49.46 %

Memphasys's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-3.884	/	( ( (13.146 - 4.874)	+	(12.43 - 5.254) )	/ 2 )
	=	-3.884	/	( ( 8.272	+	7.176 )	/ 2 )
	=	-3.884	/	7.724
	=	-50.28 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Memphasys (ASX:MEM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Memphasys ROCE % Related Terms

Thank you for viewing the detailed overview of Memphasys's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Memphasys Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (ASX:MEM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

IG7:Germany

Address

30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140

Website

https://www.memphasys.com

Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys Headlines

No Headlines